Dan Berger

430 total citations
12 papers, 354 citations indexed

About

Dan Berger is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Dan Berger has authored 12 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Toxicology. Recurrent topics in Dan Berger's work include Bioactive Compounds and Antitumor Agents (4 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Dan Berger is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Dan Berger collaborates with scholars based in United States, Netherlands and Canada. Dan Berger's co-authors include Ronald Breslow, Minu Dutia, Dennis Powell, H.H. Fiebig, Hans R. Hendriks, Gilberto Schwartsmann, Rolf Paul, Herbert M. Pinedo, R.E.C. Henrar and William Hallett and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Annals of Oncology.

In The Last Decade

Dan Berger

12 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Berger United States 10 191 186 100 52 31 12 354
J.A. Hartley United Kingdom 12 311 1.6× 155 0.8× 68 0.7× 76 1.5× 45 1.5× 22 424
Gino Beggiolin United States 10 228 1.2× 192 1.0× 218 2.2× 64 1.2× 23 0.7× 13 435
Irina Chuckowree United Kingdom 9 289 1.5× 221 1.2× 206 2.1× 45 0.9× 39 1.3× 13 504
Maurie Markman United States 8 161 0.8× 123 0.7× 134 1.3× 43 0.8× 17 0.5× 12 434
Pamela Nagafuji United States 6 248 1.3× 208 1.1× 58 0.6× 100 1.9× 57 1.8× 7 448
Evelien Smitskamp-Wilms Netherlands 9 207 1.1× 86 0.5× 114 1.1× 65 1.3× 34 1.1× 13 370
Homayon J. Arabshahi New Zealand 11 221 1.2× 254 1.4× 155 1.6× 44 0.8× 26 0.8× 17 499
Balasubramanian Gopalan India 10 229 1.2× 198 1.1× 69 0.7× 17 0.3× 16 0.5× 18 418
Tsung‐Chih Chen Taiwan 16 328 1.7× 219 1.2× 133 1.3× 125 2.4× 49 1.6× 27 550
P. F. FABIO Italy 6 179 0.9× 138 0.7× 76 0.8× 80 1.5× 15 0.5× 13 361

Countries citing papers authored by Dan Berger

Since Specialization
Citations

This map shows the geographic impact of Dan Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Berger more than expected).

Fields of papers citing papers by Dan Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Berger. The network helps show where Dan Berger may publish in the future.

Co-authorship network of co-authors of Dan Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Berger. A scholar is included among the top collaborators of Dan Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Berger. Dan Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gopalsamy, Ariamala, Mengxiao Shi, Dan Berger, et al.. (2009). Hit to lead optimization of pyrazolo[1,5-a]pyrimidines as B-Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(24). 6890–6892. 16 indexed citations
2.
Wang, Yanong D., Minu Dutia, M. Brawner Floyd, et al.. (2008). Synthesis of 7-(E)-alkenyl-4-amino-3-quinolinecarbonitriles via Pd-mediated Heck, Stille, and Suzuki reactions. Tetrahedron. 65(1). 57–61. 11 indexed citations
3.
Mallon, Robert, Larry Feldberg, Karen Collins, et al.. (2004). Identification of 4-anilino-3-quinolinecarbonitrile inhibitors of mitogen-activated protein/extracellular signal-regulated kinase 1 kinase. Molecular Cancer Therapeutics. 3(6). 755–762. 13 indexed citations
4.
Berger, Dan, Minu Dutia, Dennis Powell, et al.. (2003). Synthesis and evaluation of 4-Anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade. Bioorganic & Medicinal Chemistry Letters. 13(18). 3031–3034. 25 indexed citations
5.
6.
Berger, Dan, Minu Dutia, Dennis Powell, et al.. (2002). 8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src Kinase Inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(19). 2761–2765. 8 indexed citations
7.
Berger, Dan, Minu Dutia, Dennis Powell, et al.. (2002). Substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles as Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(20). 2989–2992. 18 indexed citations
8.
Berger, Dan, Minu Dutia, Lee M. Greenberger, et al.. (1999). Novel Multidrug Resistance Reversal Agents. Journal of Medicinal Chemistry. 42(12). 2145–2161. 60 indexed citations
9.
Breistøl, Knut, Hans R. Hendriks, Dan Berger, et al.. (1998). The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. European Journal of Cancer. 34(10). 1602–1606. 28 indexed citations
10.
Hendriks, Hans R., Dan Berger, M.C. Bibby, et al.. (1993). EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models. European Journal of Cancer. 29(6). 897–906. 89 indexed citations
11.
Hendriks, Hans R., Jacqueline Plowman, Dan Berger, et al.. (1992). Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent. Annals of Oncology. 3(9). 755–763. 25 indexed citations
12.
Breslow, Ronald, et al.. (1990). Bifunctional zinc-imidazole and zinc-thiophenol catalysts. Journal of the American Chemical Society. 112(9). 3686–3687. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.A. Hartley Breakdown of academic impact, for papers by Gino Beggiolin Breakdown of academic impact, for papers by Irina Chuckowree Breakdown of academic impact, for papers by Maurie Markman Breakdown of academic impact, for papers by Pamela Nagafuji Breakdown of academic impact, for papers by Evelien Smitskamp-Wilms Breakdown of academic impact, for papers by Homayon J. Arabshahi Breakdown of academic impact, for papers by Balasubramanian Gopalan Breakdown of academic impact, for papers by Tsung‐Chih Chen Breakdown of academic impact, for papers by P. F. FABIO
Rankless by CCL
2026